España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
AnaptysBio
ANAB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$17.93
0.51
2.93%
At close: -
$17.93
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
AnaptysBio (ANAB) Forecast
News
Earnings
AnaptysBio (ANAB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for AnaptysBio (NASDAQ:ANAB) Stock
AnaptysBio Stock (NASDAQ: ANAB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 22, 2025
Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, January 17, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, December 19, 2024
JP Morgan Maintains Overweight on AnaptysBio,...
Benzinga Newsdesk
Wednesday, December 18, 2024
Deep Dive Into AnaptysBio Stock: Analyst Perspectives (9 Ratings)
Benzinga Insights
Truist Securities Maintains Hold on AnaptysBi...
Benzinga Newsdesk
Thursday, December 12, 2024
Wells Fargo Maintains Overweight on AnaptysBi...
Benzinga Newsdesk
Guggenheim Maintains Buy on AnaptysBio, Lower...
Benzinga Newsdesk
Wednesday, December 11, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
AnaptysBio shares are trading lower after the...
Benzinga Newsdesk
AnaptysBio Discontinues Investment In Eczema Candidate After Disappointing Data
Vandana Singh
HC Wainwright & Co. Downgrades AnaptysBio to ...
Benzinga Newsdesk
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Anaptys Discontinues ANB032 Development After...
Benzinga Newsdesk
Trading Halt: Halted at 8:25:00 a.m. ET - Tra...
Benzinga Newsdesk
Monday, December 02, 2024
Key Takeaways From AnaptysBio Analyst Ratings
Benzinga Insights
AnaptysBio shares are trading lower after BTI...
Benzinga Newsdesk
BTIG Downgrades AnaptysBio to Neutral
Benzinga Newsdesk
Tuesday, November 12, 2024
JP Morgan Maintains Overweight on AnaptysBio,...
Benzinga Newsdesk
Wednesday, November 06, 2024
HC Wainwright & Co. Maintains Buy on AnaptysB...
Benzinga Newsdesk
Tuesday, November 05, 2024
AnaptysBio Q3 EPS $(1.14) Beats $(1.65) Estim...
Benzinga Newsdesk
Thursday, October 31, 2024
HC Wainwright & Co. Reiterates Buy on Anaptys...
Benzinga Newsdesk
Wednesday, October 30, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
AnaptysBio shares are trading lower. UBS main...
Benzinga Newsdesk
UBS Maintains Neutral on AnaptysBio, Raises P...
Benzinga Newsdesk
O-I Glass Posts Downbeat Results, Joins AMD, Qorvo And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, October 21, 2024
A Glimpse Into The Expert Outlook On AnaptysBio Through 6 Analysts
Benzinga Insights
Guggenheim Maintains Buy on AnaptysBio, Raise...
Benzinga Newsdesk
Monday, September 30, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, September 26, 2024
What Analysts Are Saying About AnaptysBio Stock
Benzinga Insights
Wedbush Reiterates Outperform on AnaptysBio, ...
Benzinga Newsdesk
Monday, August 19, 2024
Insiders Buying Yum China And 2 Other Stocks
Avi Kapoor
Thursday, August 15, 2024
Truist Securities Maintains Hold on AnaptysBi...
Benzinga Newsdesk
Wednesday, August 14, 2024
HC Wainwright & Co. Reiterates Buy on Anaptys...
Benzinga Newsdesk
UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
S&P 500 Rises, Small Caps Outperform As July Consumer Price Index Fuels Fed Rate Cut Hopes: 5 ETFs to Watch Wednesday
Piero Cingari
AnaptysBio shares are trading higher. The com...
Benzinga Newsdesk
AnaptysBio Announced The Pricing Of An Underw...
Benzinga Newsdesk
Wednesday, August 07, 2024
JP Morgan Maintains Overweight on AnaptysBio,...
Benzinga Newsdesk
Tuesday, August 06, 2024
4 Analysts Assess AnaptysBio: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Anaptys...
Benzinga Newsdesk
Monday, August 05, 2024
AnaptysBio Q2 2024 Adj EPS $(1.71) Misses $(0...
Benzinga Newsdesk
Monday, July 22, 2024
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
Vandana Singh
HC Wainwright & Co. Initiates Coverage On Ana...
Benzinga Newsdesk
Friday, July 19, 2024
JP Morgan Upgrades AnaptysBio to Overweight, ...
Benzinga Newsdesk
Friday, May 10, 2024
The Analyst Landscape: 7 Takes On AnaptysBio
Benzinga Insights
Wedbush Reiterates Outperform on AnaptysBio, ...
Benzinga Newsdesk
Thursday, May 09, 2024
AnaptysBio Q1 2024 Adj EPS $(1.64) Misses $(1...
Benzinga Newsdesk
Show More